Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
The standard regimen for the treatment of newly diagnosed primary CNS lymphoma (PCNSL) remains regimens that contain high-dose methotrexate (MTX). While these regimens can provide control for some patients, there is a dearth of options for the treatment of patients with PCNSL who cannot tolerate MTX...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2020-03-01
|
| Seri Bilgileri: | CNS Oncology |
| Konular: | |
| Online Erişim: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0022 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|